Detalhe da pesquisa
1.
Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy.
Br J Haematol
; 173(1): 49-58, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26728869
2.
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
Mod Pathol
; 29(8): 854-64, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27174585
3.
Detection of BCR-ABL1 mutations that confer tyrosine kinase inhibitor resistance using massively parallel, next generation sequencing.
Ann Hematol
; 95(2): 201-10, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26555285
4.
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationships.
Blood
; 121(3): 489-98, 2013 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23223358
5.
A novel approach to quantitating leukemia fusion transcripts by qRT-PCR without the need for standard curves.
Exp Mol Pathol
; 99(1): 104-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079545
6.
T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.
J Am Acad Dermatol
; 73(2): 228-36.e2, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26048061
7.
T-cell rosettes in nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 129(6): 802, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183747
8.
Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia.
Mod Pathol
; 25(6): 795-804, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22425908
9.
Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms.
Leukemia
; 34(11): 2981-2991, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32409689
10.
Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
BMC Immunol
; 10: 59, 2009 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19930596
11.
Systemic mastocytosis in a patient with Cowden syndrome.
Am J Hematol
; 89(12): 1154, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25059215
12.
Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
Am J Clin Pathol
; 152(3): 302-321, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263893
13.
Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
Methods Mol Biol
; 1908: 113-124, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30649724
14.
Molecular Fingerprinting of Anatomically and Temporally Distinct B-Cell Lymphoma Samples by Next-Generation Sequencing to Establish Clonal Relatedness.
Arch Pathol Lab Med
; 143(1): 105-111, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29979613
15.
Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
Exp Hematol
; 76: 38-48.e2, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31295506
16.
Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants.
Cancer Cell
; 36(4): 431-443.e5, 2019 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543464
17.
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.
Clin Cancer Res
; 25(7): 2323-2335, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563936
18.
Similar expression profiles in CD34+ cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib.
Oncotarget
; 9(25): 17889-17894, 2018 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29707154
19.
Detection of genome-wide copy number variants in myeloid malignancies using next-generation sequencing.
J Clin Pathol
; 71(4): 372-378, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29197855
20.
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
Am J Clin Pathol
; 128(6): 958-65, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18024321